Navigation Links
Why anorexic patients cling to their eating disorder
Date:8/3/2009

Anorexic patients drastically reduce food intake and are often not capable of changing their behavior. This can lead to life-threatening weight loss. Using MRI technology, scientists at Heidelberg University Hospital have discovered for the first time processes in brain metabolism that explain this disturbed eating behavior.

The research work of the Department of Psychosomatic and General Internal Medicine at Heidelberg University Hospital (Medical Director: Professor Dr. Wolfgang Herzog) arose in cooperation with the Heidelberg University Hospitals of General Psychiatry and Neurology. The results of the study were published in the prestigious American Journal of Psychiatry in June 2009.

Changes in brain activation associated with rigid behavior

Many young girls and women go on diets to achieve their ideal figure. Less than one percent of the population is affected by life-threatening anorexia. Despite intensive treatment, the course of the disorder is severe and chronic in 20 to 30 percent of the cases and about 10 percent of the patients die of the disease.

The Heidelberg researchers examined a total of 30 young women with and without anorexia by means of functional magnetic resonance imaging (MRI). The MRI device recorded the level of blood flow in various areas of the brain. Greater blood flow indicates higher metabolism and thus greater activity in this area of the brain.

The participants underwent a test that measured their capacity for flexible behavior modification of recently learned behavior. In this test, the subjects were shown a rapid sequence of various geometric shapes and asked to match them. After one test run, the matching principle was changed.

"In this study, we confirmed that anorexic patients cling to familiar behavioral responses more frequently than healthy subjects, thus suppressing alternative behavior," explained Dr. Hans-Christoph Friederich, head of the working group for eating disorders. The analysis of the MRI images also showed that in patients with anorexia compared with healthy subjects, a certain network pathway between the cortex and the diencephalon is less activated. This network pathway plays a decisive role in initiating and controlling actions under rapidly changing environmental demands.

New therapy approaches through brain research

The results of the study contribute decisively to a better understanding of anorexia. In particular, they make it clear that neurobiological factors are involved and sustain the clinical symptoms. Since psychological and neurobiological factors can influence each other, this may lead to new therapy approaches for anorexia.

"We have developed a treatment program for anorexia patients that specifically targets the flexible modification of behavioral responses," says Dr. Friederich. In this way, the researchers hope to improve the success of psychotherapeutic treatment. The MRI examination of the brain could contribute to measure the success of treatment.


'/>"/>

Contact: Hans-Christoph Friederich
hans-christoph_friederich@med.uni-heidelberg.de
University Hospital Heidelberg
Source:Eurekalert

Related medicine news :

1. Brain patterns of former anorexics reveal clues to disorders lasting impact
2. New Scan Spots Beginning of Bone Problems in Anorexics
3. Milkshakes are medicine for anorexic teens in family-based outpatient therapy
4. Fluctuating eye pressure associated with visual field deterioration in glaucoma patients
5. Comparison of obstetric outcomes between on-call and patients own obstetricians
6. Vision restoration therapy shown to improve brain activity in brain injured patients
7. Diabetes appears to increase risk of death for patients with acute coronary syndromes
8. Ambulatory oxygen rarely a benefit in COPD patients without resting hypoxemia
9. Restricting Blood Flow May Help Heart Bypass Patients
10. Patients with Medicaid and those lacking insurance have higher risk of advanced laryngeal cancer
11. Study provides hope that some transplant patients could live free of antirejection drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/25/2017)... ... 2017 , ... “The Majestic Unicorn”: a poignant book that describes what ... the creation of published author, Dayna Chantel, an artist and a writer. , Chantel ... march aboard the cypress ark-vessel. Male and female, no matter what species, they were ...
(Date:9/25/2017)... ... , ... The trend-spotters, tastemakers, and healthy lifestyle product experts at the ... drinks, with the new NEXTY Gold Award at the Natural Products Expo East trade ... which is reserved for just those companies that hit high marks on the criteria ...
(Date:9/25/2017)... Church, VA (PRWEB) , ... September 25, 2017 ... ... Handling and Response Preconference Workshop, **Presented by FDAnews**, Nov. 1-3, 2017 – Bethesda, ... the drugmaker passed with flying colors. And then, on the tenth inspection it ...
(Date:9/25/2017)... CA (PRWEB) , ... September 25, 2017 , ... ... music video on Thursday, September 28, 2017 to deliver a powerful message of ... On film Franchise. , Feature film writer/director Robert Adetuyi (Beat the World, Stomp ...
(Date:9/24/2017)... ... September 25, 2017 , ... Andrea Purcell, NMD, had an epiphany one evening. Four months ... her dinner plate. She thought pregnancy was so hard. She wondered why no one talks ... than her. In that moment, she decided to write what she wished her friends and ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... , Sept. 6, 2017 NeuroRx, a clinical stage ... Ideation and Behavior (ASIB), has been granted Fast Track status ... therapy of NRX-100 (ketamine HCl) followed by NRX-101 (D-cycloserine + ... pivotal trial of this sequential therapy targeting patients who are ... ...
(Date:9/5/2017)...  Xyntek Inc. has announced another milestone in their continued growth and success ... the growing demands of customer engagements regionally.  ... new Midwest office is located at 318 West Adams Street, Suite 1528, Chicago, ... Xyntek's recently opened ... ...
(Date:9/5/2017)... , Sept. 5, 2017 Oramed Pharmaceuticals Inc. ... ), a clinical-stage pharmaceutical company focused on the development ... has successfully concluded its meeting with the U.S. Food ... oral insulin formulation. ... the regulatory pathway for submission of ORMD-0801, would be ...
Breaking Medicine Technology: